These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38037472)

  • 1. Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments.
    Lago C; Federico A; Leva G; Mack NL; Schwalm B; Ballabio C; Gianesello M; Abballe L; Giovannoni I; Reddel S; Rossi S; Leone N; Carai A; Mastronuzzi A; Bisio A; Soldano A; Quintarelli C; Locatelli F; Kool M; Miele E; Tiberi L
    EMBO Mol Med; 2023 Dec; 15(12):e18199. PubMed ID: 38037472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology.
    Xu X; Kumari R; Zhou J; Chen J; Mao B; Wang J; Zheng M; Tu X; An X; Chen X; Zhang L; Tian X; Wang H; Dong X; Bao Z; Guo S; Ouyang X; Shang L; Wang F; Yan X; Zhang R; Vries RGJ; Clevers H; Li QX
    PLoS One; 2023; 18(1):e0279821. PubMed ID: 36602988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity.
    Kopper O; de Witte CJ; Lõhmussaar K; Valle-Inclan JE; Hami N; Kester L; Balgobind AV; Korving J; Proost N; Begthel H; van Wijk LM; Revilla SA; Theeuwsen R; van de Ven M; van Roosmalen MJ; Ponsioen B; Ho VWH; Neel BG; Bosse T; Gaarenstroom KN; Vrieling H; Vreeswijk MPG; van Diest PJ; Witteveen PO; Jonges T; Bos JL; van Oudenaarden A; Zweemer RP; Snippert HJG; Kloosterman WP; Clevers H
    Nat Med; 2019 May; 25(5):838-849. PubMed ID: 31011202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting.
    Aizawa Y; Takada K; Aoyama J; Sano D; Yamanaka S; Seki M; Kuze Y; Ramilowski JA; Okuda R; Ueno Y; Nojima Y; Inayama Y; Hatakeyama H; Hatano T; Takahashi H; Nishimura G; Fujii S; Suzuki Y; Taniguchi H; Oridate N
    Cell Oncol (Dordr); 2023 Apr; 46(2):409-421. PubMed ID: 36538240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening.
    Gamboa CM; Jara K; Pamarthy S; Liu L; Aiken R; Xiong Z; Danish S; Sabaawy HE
    STAR Protoc; 2021 Mar; 2(1):100345. PubMed ID: 33665625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.
    Pamarthy S; Sabaawy HE
    Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived organoids as a model for tumor research.
    Wang J; Feng X; Li Z; Chen Y; Huang W
    Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro drug testing using patient-derived ovarian cancer organoids.
    Chen LY; Chou YT; Liew PL; Chu LH; Wen KC; Lin SF; Weng YC; Wang HC; Su PH; Lai HC
    J Ovarian Res; 2024 Oct; 17(1):194. PubMed ID: 39358778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
    Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
    Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of patient-derived organoid models of lower-grade glioma.
    Abdullah KG; Bird CE; Buehler JD; Gattie LC; Savani MR; Sternisha AC; Xiao Y; Levitt MM; Hicks WH; Li W; Ramirez DMO; Patel T; Garzon-Muvdi T; Barnett S; Zhang G; Ashley DM; Hatanpaa KJ; Richardson TE; McBrayer SK
    Neuro Oncol; 2022 Apr; 24(4):612-623. PubMed ID: 34850183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation, Expansion, and Biobanking of Gastrointestinal Patient-Derived Organoids from Tumor and Normal Tissues.
    Cabeza-Segura M; Garcia-Micó B; Cervantes A; Castillo J
    Methods Mol Biol; 2024; 2777():123-133. PubMed ID: 38478340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.
    Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ
    Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Derived Organoids from Locally Advanced Gastric Adenocarcinomas Can Predict Resistance to Neoadjuvant Chemotherapy.
    Yoon C; Lu J; Kim BJ; Cho SJ; Kim JH; Moy RH; Ryeom SW; Yoon SS
    J Gastrointest Surg; 2023 Apr; 27(4):666-676. PubMed ID: 36627466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours.
    Fusco P; Parisatto B; Rampazzo E; Persano L; Frasson C; Di Meglio A; Leslz A; Santoro L; Cafferata B; Zin A; Cimetta E; Basso G; Esposito MR; Tonini GP
    BMC Cancer; 2019 Oct; 19(1):970. PubMed ID: 31638925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling.
    Van Hemelryk A; Tomljanovic I; de Ridder CMA; Stuurman DC; Teubel WJ; Erkens-Schulze S; Verhoef EI; Remmers S; Mahes AJ; van Leenders GJLH; van Royen ME; van de Werken HJG; Grudniewska M; Jenster GW; van Weerden WM
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models.
    Wang E; Xiang K; Zhang Y; Wang XF
    J Natl Cancer Cent; 2022 Dec; 2(4):263-276. PubMed ID: 39036550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-derived Tumour Organoids: A Bridge between Cancer Biology and Personalised Therapy.
    Wu W; Li X; Yu S
    Acta Biomater; 2022 Jul; 146():23-36. PubMed ID: 35533925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-derived Organoids in Bladder Cancer: Opportunities and Challenges.
    Radić M; Egger M; Kruithof-de Julio M; Seiler R
    Eur Urol Focus; 2024 Sep; ():. PubMed ID: 39232905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of Human Pituitary Neuroendocrine Tumor Derived Organoid and Its Pilot Application for Drug Screening.
    Cui R; Duan H; Hu W; Li C; Zhong S; Liang L; Chen S; Hu H; He Z; Wang Z; Guo X; Chen Z; Xu C; Zhu Y; Chen Y; Sai K; Yang Q; Guo C; Mou Y; Jiang X
    J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38656317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.